BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35383196)

  • 21. Altered expression of retinal molecular markers in the canine RPE65 model of Leber congenital amaurosis.
    Hernández M; Pearce-Kelling SE; Rodriguez FD; Aguirre GD; Vecino E
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6793-802. PubMed ID: 20671290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse correlation between fatty acid transport protein 4 and vision in Leber congenital amaurosis associated with RPE65 mutation.
    Li S; Gordon WC; Bazan NG; Jin M
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32114-32123. PubMed ID: 33257550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cone photoreceptor dependence on RPE65 isomerase.
    Jacobson SG; Aleman TS; Cideciyan AV; Heon E; Golczak M; Beltran WA; Sumaroka A; Schwartz SB; Roman AJ; Windsor EA; Wilson JM; Aguirre GD; Stone EM; Palczewski K
    Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15123-8. PubMed ID: 17848510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of thyroid hormone receptor locally in the retina is a therapeutic strategy for retinal degeneration.
    Ma H; Yang F; Butler MR; Belcher J; Redmond TM; Placzek AT; Scanlan TS; Ding XQ
    FASEB J; 2017 Aug; 31(8):3425-3438. PubMed ID: 28428265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration.
    Mookherjee S; Chen HY; Isgrig K; Yu W; Hiriyanna S; Levron R; Li T; Colosi P; Chien W; Swaroop A; Wu Z
    Cell Rep; 2018 Oct; 25(3):611-623.e6. PubMed ID: 30332642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing.
    Jo DH; Jang HK; Cho CS; Han JH; Ryu G; Jung Y; Bae S; Kim JH
    Mol Ther Nucleic Acids; 2023 Mar; 31():16-27. PubMed ID: 36589710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.
    Pang J; Boye SE; Lei B; Boye SL; Everhart D; Ryals R; Umino Y; Rohrer B; Alexander J; Li J; Dai X; Li Q; Chang B; Barlow R; Hauswirth WW
    Gene Ther; 2010 Jul; 17(7):815-26. PubMed ID: 20237510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
    Jacobson SG; Cideciyan AV; Ratnakaram R; Heon E; Schwartz SB; Roman AJ; Peden MC; Aleman TS; Boye SL; Sumaroka A; Conlon TJ; Calcedo R; Pang JJ; Erger KE; Olivares MB; Mullins CL; Swider M; Kaushal S; Feuer WJ; Iannaccone A; Fishman GA; Stone EM; Byrne BJ; Hauswirth WW
    Arch Ophthalmol; 2012 Jan; 130(1):9-24. PubMed ID: 21911650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of the transcription factor Mef2c during retinal degeneration in Rpe65-/- mice.
    Escher P; Schorderet DF; Cottet S
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5933-40. PubMed ID: 21715356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photoreceptor layer topography in children with leber congenital amaurosis caused by RPE65 mutations.
    Jacobson SG; Cideciyan AV; Aleman TS; Sumaroka A; Windsor EA; Schwartz SB; Heon E; Stone EM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4573-7. PubMed ID: 18539930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of the transient pupillary light reflex in Rpe65(-/-) mice and humans with leber congenital amaurosis.
    Aleman TS; Jacobson SG; Chico JD; Scott ML; Cheung AY; Windsor EA; Furushima M; Redmond TM; Bennett J; Palczewski K; Cideciyan AV
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1259-71. PubMed ID: 15037595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cone outer segment morphology and cone function in the Rpe65-/- Nrl-/- mouse retina are amenable to retinoid replacement.
    Kunchithapautham K; Coughlin B; Crouch RK; Rohrer B
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4858-64. PubMed ID: 19407011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cone opsin determines the time course of cone photoreceptor degeneration in Leber congenital amaurosis.
    Zhang T; Zhang N; Baehr W; Fu Y
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8879-84. PubMed ID: 21555576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.
    Koirala A; Makkia RS; Conley SM; Cooper MJ; Naash MI
    Hum Mol Genet; 2013 Apr; 22(8):1632-42. PubMed ID: 23335596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic deletion of S-opsin prevents rapid cone degeneration in a mouse model of Leber congenital amaurosis.
    Zhang T; Enemchukwu NO; Jones A; Wang S; Dennis E; Watt CB; Pugh EN; Fu Y
    Hum Mol Genet; 2015 Mar; 24(6):1755-63. PubMed ID: 25416279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.
    Jacobson SG; Aleman TS; Cideciyan AV; Roman AJ; Sumaroka A; Windsor EA; Schwartz SB; Heon E; Stone EM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2368-75. PubMed ID: 19117922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ablation of fatty acid transport protein-4 enhances cone survival, M-cone vision, and synthesis of cone-tropic 9-
    Li S; Jin M
    J Neurosci; 2024 May; ():. PubMed ID: 38811164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
    Weleber RG; Pennesi ME; Wilson DJ; Kaushal S; Erker LR; Jensen L; McBride MT; Flotte TR; Humphries M; Calcedo R; Hauswirth WW; Chulay JD; Stout JT
    Ophthalmology; 2016 Jul; 123(7):1606-20. PubMed ID: 27102010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.
    Georgiadis A; Duran Y; Ribeiro J; Abelleira-Hervas L; Robbie SJ; Sünkel-Laing B; Fourali S; Gonzalez-Cordero A; Cristante E; Michaelides M; Bainbridge JW; Smith AJ; Ali RR
    Gene Ther; 2016 Dec; 23(12):857-862. PubMed ID: 27653967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.